- Drug Pipelines
- August 2020
- 693 Pages
Global
From €1768EUR$2,000USD£1,536GBP
- Report
- February 2024
- 100 Pages
Global
From €4200EUR$4,750USD£3,647GBP
- Report
- July 2024
- 134 Pages
Global
From €2210EUR$2,500USD£1,920GBP
- Report
- September 2024
- 179 Pages
Global
From €2210EUR$2,500USD£1,920GBP
- Report
- August 2024
- 184 Pages
Global
From €2210EUR$2,500USD£1,920GBP
- Report
- July 2024
- 138 Pages
Global
From €2210EUR$2,500USD£1,920GBP
- Report
- June 2024
- 171 Pages
Global
From €2210EUR$2,500USD£1,920GBP
- Report
- May 2024
- 170 Pages
Global
From €2210EUR$2,500USD£1,920GBP
- Report
- March 2024
- 175 Pages
Global
From €2210EUR$2,500USD£1,920GBP
- Report
- July 2022
- 64 Pages
Global
From €1768EUR$2,000USD£1,536GBP
- Report
- May 2022
- 38 Pages
Global
From €1768EUR$2,000USD£1,536GBP
- Drug Pipelines
- March 2021
Global
From €2210EUR$2,500USD£1,920GBP
- Drug Pipelines
- October 2020
- 151 Pages
Global
From €1768EUR$2,000USD£1,536GBP
- Report
- June 2024
- 188 Pages
Global
From €3979EUR$4,500USD£3,455GBP
- Report
- March 2023
- 64 Pages
Africa, Middle East
From €1326EUR$1,500USD£1,152GBP
- Report
- March 2023
- 64 Pages
Asia Pacific
From €1326EUR$1,500USD£1,152GBP
- Report
- March 2023
- 64 Pages
Europe
From €1326EUR$1,500USD£1,152GBP
- Report
- March 2023
- 59 Pages
North America
From €1326EUR$1,500USD£1,152GBP
- Report
- March 2023
- 130 Pages
Global
From €3183EUR$3,600USD£2,764GBP
- Report
- June 2024
- 99 Pages
Asia Pacific
From €1326EUR$1,500USD£1,152GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more